Atlas Trials

Recurrent or Metastatic Nasopharyngeal Carcinoma

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent or Metastatic Nasopharyngeal Carcinoma

RecordFirmDate
Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL) (NCT04996758)Sun Yat-sen University2021-10-30

Track Recurrent or Metastatic Nasopharyngeal Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.